COPA-DATA UK has released a white paper investigating the state of security in the pharmaceutical manufacturing sector. In the paper, COPA-DATA addresses the reasons why the pharmaceutical industry is so much more vulnerable to attacks and examines some of the most effective security tools that companies have at their disposal in the era of Industry 4.0. Cyber security threats are prevalent in almost every industry. However, according to the latest reports, the healthcare and pharmaceutical sectors are falling behind in the cyber security race. With the number and complexity of cyber threats on the rise, pharmaceutical manufacturers need to change the way they think about industrial security.
In the white paper, COPA-DATA investigates how pharmaceutical companies can leverage the benefits of new technologies, like the Industrial Internet of Things, while minimising cyber security risks.
Martyn Williams, Manager Director at COPA-DATA UK explains: “The estimated cost of cybercrime to the UK economy is said to be around £27 billion annually. In fact, the same industry report named the pharmaceutical and biotech sectors amongst the hardest hit industries.
“The objective of the white paper is to educate pharmaceutical manufacturers of the potential risks they face and highlight the best methods to minimise these risks. The white paper also discusses how pharmaceutical manufacturers can use compliance procedures to their advantage and employ intelligent SCADA software to reduce the likelihood of cyber attacks.”